Anti-COVID-19 vaccines and rare cases of cerebral venous sinus thrombosis with thrombocytopenia: what about the pragmatic benefit/risk evaluation for still unvaccinated young women
- 20 January 2022
- journal article
- editorial
- Published by Taylor & Francis Ltd in Expert Review of Vaccines
- Vol. 21 (4), 1-3
- https://doi.org/10.1080/14760584.2022.2031986
Abstract
The use of ChAdOx1 and Ad26.COV2.S anti-COVID-19 adenovirus vector vaccines has been associated with unusual cases of cerebral venous sinus thrombosis (CVST) with thrombocytopenia and anti-platelet...This publication has 17 references indexed in Scilit:
- SARS-CoV-2 vaccines, where do we stand?Comptes Rendus Biologies, 2021
- Procoagulant microparticles: a possible link between vaccine-induced immune thrombocytopenia (VITT) and cerebral sinus venous thrombosisJournal of Thrombosis and Thrombolysis, 2021
- First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in ScotlandNature Medicine, 2021
- Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients — United States, April 2021Morbidity and Mortality Weekly Report (MMWR), 2021
- Thromboembolism and the Oxford–AstraZeneca COVID-19 vaccine: side-effect or coincidence?The Lancet, 2021
- Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trialsThe Lancet, 2021
- Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health SystemJAMA, 2020
- Derivation and Validation of a Prediction Model for Venous Thromboembolism in Primary CareThrombosis and Haemostasis, 2020